Photetica

History

Photetica has developed a patented science delivered in a medical device that provides a unique phototherapy technology; the company's focus is treating patients that are currently under going chemotherapy treatment, and diabetics. Patients undergoing chemotherapy face a variety of potential side effects -- nausea, sleeplessness, pain, CIPN (chemotherapy induced peripheral neuropathy--the number one cause for discontinuing chemotherapy), hair loss and a de-stablized immune system often resulting in a reduced white blood cell count that causes the temporary or permanent ceasing of a chemotherapy treatment plan. According to www.ons.org (2011), CIPN is caused by five major drug classes: Taxanes, Platinums, Vinca alkaloids, Protease inhibitors, and Anti-angiogenesis agents.

Specialties

Photetica is a pre market medical device company that offers the only patented treatment for CIPN, Diabetic peripheral neuropathy, and peripheral neuropathy